Relatively large amounts of a glycoprotein, designated gp70 because of its molecular weight of 70,000 and its structural and immunologic similarity to retroviral envelope protein, circulate in the blood of many murine strains free from any association with viral particles (1) (2) (3) (4) (5) . Although one finds multiple immunologically and structurally related gp70 in all mice, the structure of this serum gp70 molecule most closely resembles, but is not identical by peptide fingerprint analysis, to the coat protein of xenotropic virus isolated only from NZB and NZB × NZW F1 hybrid (NZB × W) mice (5) (6) (7) .
The origin of serum gp70 and the mechanisms controlling its expression are still unclear. Although lymphoid cells express virion-free gp70 on their surfaces (8) (9) (10) , these cells do not seem to be a major source for serum gp70, because neither thymectomy nor splenectomy affects serum levels of gpT0 (11) . A tissue or organ that is directly or indirectly responsive to testosterone was suggested as the origin of serum gp70 (11) ; however, no serological or immunohistochemical evidence indicates either production or subsequent release of gp70 into the circulating blood by any organ or tissue.
In recent experiments (12) , a single injection of bacterial lipopolysaccharide (LPS) 1 greatly enhanced the expression of serum gp70 in murine strains with high baseline levels of gp70 (>10 #g/ml) such as NZB, NZB × W, NZW, BXSB, DBA/2, 129(Gix+), but not in those with lower levels (<5 #g/ml) including C57BL/6, BALB/c, or 129(Gix-). This increased expression of serum gp70 was unrelated to the activation of endogenous xenotropic virus or other viral genomes. Therefore, this experimental model seemed suitable for investigation of the cellular origin of serum gp70 and the control mechanism for its production. Our results indicate that serum gp70 behaves like an acute phase reactant (APR) and is synthesized mainly by hepatic cells, as are many other APR and serum proteins.
by using 131I-labeled bovine serum albumin (BSA; Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.) as a volume marker according to the modified procedure of Mathison and Ulevitch (21) . Briefly, 0.2-0.3 mg of I~II-BSA with a specific activity of 1.5-2.5 #Ci/#g was injected intravenously into NZB × W female mice, whose sera were collected 3 h later. The radioactivity of sera with approximately 15-20 #Ci/ml was >90% precipitable in. 10% trichloroacetic acid. 50-100-#1 samples containing 1 × I06-2 × 10 s cpm of t81I-BSA were then injected intravenously into 2-too-old NZB × W female mice 5 rain before killing. On the basis of counts per minute per ml of tissue extract and per ml of blood, the blood content in various tissue extracts was calculated. From the measurement of gp70 content in tissue extracts and in blood, the amounts of gp70 present in tissue were computed.
Fluorescence Microscopy for Detection ofgp70 in Livers.
To localize gp70 in livers of test mice, each liver was perfused with 0.05 M PBS, pH 7.2, and with the periodatedysine-paraformaldehyde (PLP) solution as described by McLean and Nakane (22) . Then, 2-4 mm liver fragments were fixed with PLP for 3 h at 4°C and washed, first with 7% sucrose in PBS, then with 15% sucrose in PBS, and finally with PBS containing 25% sucrose and 20% glycerol. The fixed liver samples were embedded in AmesOCT compound, quick frozen, and sectioned into 4-#m slices on a cryostat at -35°C. To demonstrate gpT0 in this tissue, sections were incubated with the IgG fraction of goat anti-Rauscher MuLV gp70 (the gift of Dr. J. H. Elder, Scripps Clinic and Research Foundation) or normal goat IgG for 30 rain at room temperature. After being washed, fluorescein isothiocyanate-conjugated rabbit anti-goat IgG (N. L. Cappel Laboratories) was applied for 30 rain at room temperature. The specificity of fluorescence was controlled by absorbing the goat anti-Rauscher MuLV gp70 with Rauscher MuLV. For this purpose, antigp70 IgG (0.5 ml ofa 6 mg/ml solution) was incubated with 3 mg Rauscher MuLV for 30 rain at 37°C, followed by centrifugation at 100,000 g for 60 rnin at 4°C. The resulting supernatant was used as absorbed antibodies.
Results

Induction of High Serum Levels of gp70 in Mice by LPS.
In 2-mo-old NZB female mice whose baseline levels of serum gp70 were 46:1:12 #g/ml, the injection of 25 #g i.p. of LPS from E. coli 0111 :B4 caused an increase of gp70 to 376 :t: 73 #g/ml within 24 h. This gp70 response was dose related (Fig. 1) . Serum gp70 concentrations increased significantly after injection of 25 ng of LPS (137 + 27 #g/ml) and reached nearmaximal responses with 25 #g of LPS in NZB mice. Results were similar in strains with high baseline levels of serum gp70 (>10 #g/ml) such as NZB X W, BXSB, DBA/ 2, and 129(Glx +) mice. However, murine strains with low serum gp70 (<5 #g/ml) such as C57BL/6 or BALB/c mice showed no increase in serum gp70 at any dose of LPS, as described previously (12) .
To define that portion of the LPS molecule responsible for stimulating gp70 response, the lipid A fraction extracted from S. minnesota R595 LPS and lipid A-free preparations ofF_., coli 0113 LPS, such as NPP and alkali-treated LPS, were tested for gp70-producing capacity in NZB x W mice. The injection of purified lipid A induced serum levels of gp70 about equal to those stimulated by the entire LPS molecule (Table I ). In contrast, NPP and alkali-treated LPS preparations, both of which lack the lipid A component, induced only minimal activity. * 50 #g of each LPS preparation was injected i.p. on day 0 into 2-mo-old NZB X W male mice. LPS, NPP, and alkali-treated LPS were purified from E. coli 0113 and lipid A from S. minnesota R595. Note that both NPP and alkali-treated LPS lacked lipid A. :~ Mean ± 1 SD for five mice. ment-treated syngeneic bone marrow cells) received 25 #g LPS i.p., their serum gp70 responses were compared with those of unmanipulated NZB × W mice. LPS increased serum gp70 levels from 61 + 22 #g/ml to 336 ± 82 #g/rnl in T cell-depleted mice. This increased response was only slightly lower than that in controls with normal numbers ofT cells (from 62 + 11 #g/ml to 590 ± 69 #g/ml), thus excluding a major role of T cells in serum gp70 responses induced by LPS.
Unrelatedness of
LPS is a potent B cell activator (23) , and the activation of B cells might account for the enhanced expression of gp70 on their surfaces (24, 25) . Therefore, we examined the possible relationship between synthesis of serum gp70 promoted by LPS and the activation of B cells, measured as serum levels of polyclonal IgM antibodies. For this purpose, 2-mo-old NZB × W mice were lethally irradiated (1,000 rad), and 2 d later, were injected with 25 #g of LPS. 1 d after injection of LPS, concentrations of serum gp70 were ~ 10 times as high as those before injection of LPS regardless of irradiation (Table II) . However, 5 d after the injection of LPS, serum IgM levels doubled in unirradiated mice, but actually dropped in irradiated mice. Radiation alone had no significant effect on serum levels of gp70, but again somewhat decreased the concentrations of serum IgM.
To confirm that the activation of lymphocytes was unrelated to the LPS-induced serum gp70 response, this response was examined in radiation chimeras of 129(Gix +) and 129(Gxx-) congenic mice. It had been shown that LPS enhances the expression of serum gp70 in the former high gp70 mice but not in the latter (12) , which have much lower concentrations of gp70 in sera and on the surface of lymphocytes (2, 10, 12) . Baseline levels of serum gp70 in irradiated 129(GLX +) or 129(Gix-) mice reconstituted with reciprocal spleen cells were comparable to those of untreated 129(Gtx ÷) or 129(Cnx-) mice, regardless of the donor's cell type (Table III) . Unmanipulated Gxx + mice and Cnx ÷ mice given Gix-spleen cells responded equally well to the injection of 25 #g of LPS, developing high serum levels of gp70. However, little increase in serum gp70 was seen in 129(Gzx-) recipients reconstituted with Gix + spleen ceils or unmanipulated 129(Cnx-) mice. It should be noted that a higher frequency of gp70-positive cells in the spleens of Gin-mice reconstituted with Gtx + cells than in GIx + mice given Gix-cells revealed that spleen cells of both chimeras were of donor type. Further, sera of both groups of mice developed comparable amounts of polyclonal IgM antibodies as a result of B cell activation by LPS (Table III) .
Serum gp70 as an APR. Because LPS is a potent inducer of APR (26) (27) (28) , the kinetics of serum gp70 responses were compared with those of the APR, haptoglobin, in LPS-injected NZB × W female mice. Serum levels of both gp70 and haptoglobin increased as early as 6 h after the injection and peaked at ~24 h, although gp70 levels returned to the preinjection levels more rapidly than those of haptoglobin (Fig. 2) . At their peaks, gp70 and haptoglobin levels were -t0 times higher than those before injection of LPS.
The possible stimulation of serum gp70 synthesis by various inducers of APR was also investigated. NZB × W male mice were injected intraperitoneally with 0.01 or 0.05 ml of turpentine oil or 100, 200, or 500 #g ofpoly I-poly C. 1 d after the injection, dose-dependent increases of serum gp70 and of haptoglobin were observed in the animals injected with turpentine oil or poly I-poly C (Table IV) . 0.05 ml of turpentine oil and 500 #g of poly I-poly C induced the production of haptoglobin and serum gp70 as effectively as 25 #g of LPS. This finding was confirmed in DBA/2 and BXSB mice, which are natively high in serum gp70 concentrations (data not shown). Table IV also shows that although LPS stimulated the production of serum IgM as a result of B cell activation, neither turpentine oil nor poly I-poly C elevated the serum levels of IgM, ruling out possible contamination by LPS in preparations of turpentine oil and poly I-poly C.
Tissue Origin of Serum gp70 Induced by LPS. Because, in the foregoing experiments, the induction of serum gp70 by LPS was apparently unrelated to the activation of 400 -t 300-~gp7Q ~"" lymphocytes, we sought this glycoprotein's site of origin in the liver, a major source of many other serum proteins. The effect of colchicine, an inhibitor of the plasma protein's secretion from the liver, on serum gp70 responses to LPS was examined in NZB × W male mice. Inoculation of 25/xg LPS followed 3 h later by 100/~g of colchicine yielded greatly suppressed rises in serum levels of gp70 compared to those induced by LPS alone (Fig. 3) . 12 h after injection of LPS in colchicine-treated mice, serum levels of gp70 were less than one third (133 ± 25 #g/ml) of those in mice receiving LPS alone (449 + 25 /~g/ml). Less, but still significant suppression was observed in mice injected with 15/~g colchicine (215 -/-47/~g/ml). Colchicine alone did not significantly change baseline levels of gpT0 in serum.
With this experimental system, the quantity of gp70 in various organs was then determined in NZB × W female mice. The first group of mice were injected with 25 #g LPS alone, the second with 25 pg LPS and 3 h later 100 #g of colchicine, the third with colchicine alone, and the fourth with saline alone (controls). gp70 was quantitated in livers, kidneys, spleens, thymuses, and lungs as well as in sera 9 h after the injection of LPS. The amounts of gp70 recoverable in liver extracts were 3.3 times higher in mice receiving LPS alone than in saline-injected controls (Table V) . However, other tissue extracts did not show this remarkable increase in the amounts of gp70. The subsequent injection of colchicine in LPS-treated mice further increased the amounts of gp70 in their livers, but not in any other tissues tested. The liver extracts from such mice contained 2.4 times as much gp70 as those from the animals injected with LPS alone, or 7.8 times as much as those from saline controls, in striking contrast to the blunted serum gp70 responses in colchicine-treated mice. Livers from animals treated with colchicine alone contained 2.3 times higher concentrations of gp70 than saline-injected controls. It was noteworthy that levels of gp70 in sera and livers never increased after injection of LPS administered simultaneously with DGalN, an inhibitor of protein synthesis (Table VI) .
To further identify the cellular origin of gp70, livers from NZB × W mice were analyzed immunohistochemically. Antiserum specific for Rauscher MuLV gp70 * Amounts of gp70 in sera and in tissues were determined 9 h after the injection of LPS. Mean 4-1 SD for seven mice.
:~ 25 #g of LPS from E. coh" 01 t 1 :B4 was injected i,p. into 2-mo-old NZB × W female mice. § 100 pg of eolchicine was injected i.p. 3 h after the injection of LPS. scarcely stained hepatocytes of untreated mice examined by indirect immunofluorescence (Fig. 4 A) . However, livers of mice obtained 6 h after administration of LPS began to show a fine granular staining of gp70 in most hepatocytes and in some sinusoidal margins, and at 9 h the distribution of gp70 was more extensive. Compared with mice injected with LPS alone, livers from mice receiving both LPS and colchicine showed more intense, coarse granular staining of gp70 in the cytoplasm of virtually all the hepatocytes without appreciable staining along the sinusoids (Fig. 4 B) . Liver sections from mice treated with colchicine alone also had increased numbers of gp70-positive hepatocytes, After absorption of antisera to Rauscher MuLV gp70 with Rauscher MuLV, no positive staining appeared, Liver sectiotls from BALB/c or C57BL/6 mice, which do not produce gp70 after injection of LPS (12) , showed no such specific staining, even after treatment with LPS and colchicine.
TABLE VI
Suppression of LPS-Induced gp 70 Response in Serum and Liver by n-GalN
Discussion
Using an experimental model in which the expression of serum gp70 is greatly enhanced after the injection of LPS (12), we have demonstrated that this gp70 behaves as an APR and is mainly synthesized by hepatic cells. Apparently, this glycoprotein is significantly involved as an autoantigen in the pathogenesis of murine systemic lupus erythematosus (7, 17, (29) (30) (31) .
Lymphocytes have been suggested as the major source of serum gp70 (10) . Indeed, lymphocytes express surface gp70 molecules with characteristics similar to serum gp70 (10, 32) , and enhanced production of serum gp70 induced by LPS is seen only in murine strains whose thymocytes are positive for Cox antigen (12), a type-specific determinant of the gp70 molecule (2, 9, 10, 33) . However, our results refute this possibility. First, T cell-depleted mice produce as much serum gp70 as mice with normal numbers of T cells after the injection of LPS, Second, the production of gp70 is independent of the activation of B cells, because lethal irradiation of mice preceding the injection of LPS completely abolishes the activation of B ceils, but has no effect on the serum gp70 response. Further, gp70 production is stimulated by such inducers of APR as turpentine oil or poly I-poly C without significant formation of polyclonal IgM antibodies. Finally, 129(Gtx +) mice produce gp70 after stimulation with LPS, even after irradiation and reconstitution with spleen cells from Gix-mice. To the contrary, 129(Gtx-) mice either unmanipulated or replenished with Gix + spleen cells develop no serum gp70 responses. This experiment with radiation chimeras clearly indicates that the ability to generate a serum gp70 response is not dependent on the genotype of spleen cells, but rather related to that of nonlymphoid tissues. Of note, both chimeras developed equally high levels of polyclonal antibodies as a result of B cell activation. These results are consistent with a previous report (11) that neither thymectomy, splenectomy, nor exchange of hematopoietic tissues between 129(GIx +) and 129(Gtx-) mice affected levels of serum gp70 in either strain. All these findings exclude lymphoid cells as a major source of serum gp70.
Instead, our results strongly suggest the liver as the major site of serum gp70 production. The experimental observations that support this conclusion are: First, amounts of gp70 present in liver extracts of LPS-injected mice were more than three times higher than in uninjected controls, whereas no such increase appeared in other tissues including the lung, kidney, spleen, or thymus. Second, the injection of colchicine, which is a known inhibitor of protein release from hepatic cells (34, 35) , greatly suppressed the serum gp70 response. Accordingly, increased amounts of gp70 were recoverable from liver extracts but not other tissue extracts, indicating the accumulation of newly synthesized gp70 in hepatic cells as colchicine inhibited its release. Third, o-GaiN, an inhibitor of protein synthesis (36, 37) , completely prevented increase of gp70 in the liver or serum after the injection of LPS. Finally, immunohistochemical study more directly showed the presence of gp70 as fine granules in the cytoplasm of hepatic parenchymal cells from mice receiving LPS. Subsequent treatment with colchicine intensified this specific staining by gp70 in almost all the hepatocytes. In all probability, hepatic cells are the major source of the gp70 that eventually enters the circulation. This conclusion is compatible with the fact that the concentration of gp70 in sera is generally 20-100% higher in male mice than females (11, 12, 17) . The liver is a known source of several proteins whose serum concentrations are associated markedly with the host's sex depending on androgenic hormones (38) .
A particularly significant observation in this research is that serum gp70 behaves like an APR. Not only LPS but also other inducers of APR, such as turpentine oil or poly I-poly C (39, 40) , enhanced the synthesis of serum gp70. Notably, neither turpentine oil nor poly I-poly C activated B cells to produce polyclonal antibodies, ruling out possible contamination with LPS in these preparations. Further, the kinetics of this gp70 response were essentially identical to those of such APR as haptoglobin, serum amyloid A protein, or C-reactive protein (26) (27) (28) . Finally, we recently demonstrated that restriction of calorie intake in NZB × W mice reduced serum levels of the APR, haptoglobin, as well as gp70, but not that of albumin (41) . Consequently, serum gp70 has the qualities of an APR, and its expression is controlled by a mechanism similar to that for other APR. Hepatic cells undoubtedly synthesize gp70 and release it into the circulation as they do other APR (26, 28, 39, 42, 43) .
In view of (a) the similarity in expression of serum gp70 and a number of other proteins that are products of the host genome, (b) the failure of other retroviral gene (even env gene) products to be expressed along with serum gp70, and (c) the slight but demonstrable differences between serum gp70 and the known products of any retroviral env gene, it seems that this molecule behaves as a host gene product.
Summary
A single intraperitoneal injection of bacterial lipopolysaccharide (LPS) or its lipid A component induced high levels of glycoprotein, gp70, in sera of several strains of mice within 24 h. This serum gp70 response induced by LPS was independent of the activation of B cells and the presence of T cells. However, serological and immunohistochemical studies demonstrated the production of gp70 by hepatic parenchymal ceils and its subsequent release into the circulating blood.
The expression of gp70 in the serum was enhanced not only by LPS but also other inducers of acute phase reactants (APR) such as turpentine oil or polyriboinosinicpolyribocytidylic acid. Further, the serum gp70 response was kinetically identical to those of APR. These results strongly suggest that (a) the liver may be the major source for serum gp70, (b) serum gp70 behaves like an APR, (c) its expression may be controlled by a mechanism similar to that for other APR, and (at) this glycoprotein apparently behaves as a normal host constituent and not a product of a viral genome.
